Côte d'Ivoire vs Myanmar: Treatment success rate for patients treated for MDR-TB
Côte d'Ivoire
75.0%
in 2022
Myanmar
75.0%
in 2022
Côte d'Ivoire rank
70th
Myanmar rank
70th
Treatment success rate for patients treated for MDR-TB over time
- Côte d'Ivoire
- Myanmar
How they compare
Côte d'Ivoire currently reports 75.0% against 75.0% in Myanmar, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2013 it was Côte d'Ivoire ahead.
Côte d'Ivoire ranks 70th and Myanmar ranks 70th of 163 countries.
Across the 2 decades both report, Côte d'Ivoire averaged higher in 1 and Myanmar in 1.
Head to head by decade
| Decade | Côte d'Ivoire | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.4% | 79.4% | 2.0% | Myanmar |
| 2020s | 76.0% | 75.3% | 0.7% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Côte d'Ivoire or Myanmar?
- Côte d'Ivoire, at 75.0% against 75.0% in Myanmar as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Côte d'Ivoire and Myanmar?
- 0.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Myanmar?
- 10 years are reported by both, from 2013 to 2022.
- How do Côte d'Ivoire and Myanmar rank globally for treatment success rate for patients treated for mdr-tb?
- Côte d'Ivoire ranks 70th and Myanmar ranks 70th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.